pan CEA Antibody (B-1): sc-398456
- pan CEA Antibody (B-1) is a mouse monoclonal IgG2b κ provided at 200 µg/ml
- specific for an epitope mapping between amino acids 106-139 within an internal region of CEACAM5 of human origin
- recommended for detection of a broad range of CEACAM family members of human origin by WB, IP, IF and ELISA
- m-IgG2b BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for pan CEA Antibody (B-1) for WB applications. These reagents are now offered in bundles with pan CEA Antibody (B-1) (see ordering information below).
QUICK LINKS
SEE ALSO...
pan CEA Antibody (B-1) is a mouse monoclonal IgG2b antibody that detects carcinoembryonic antigen (CEA) in human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Carcinoembryonic antigen plays a crucial role in cell adhesion and signaling, which is vital for maintaining tissue architecture and facilitating communication between cells. CEA is primarily located on the cell surface, where CEA participates in various cellular processes, including the regulation of immune responses and the promotion of tumor progression. CEA presence in serum is often associated with certain types of cancer, making CEA an important biomarker for diagnosis and monitoring treatment efficacy. anti-CEA antibody (B-1) provides reliable detection of CEA, enabling researchers to explore CEA functions and interactions in both normal and pathological states, thereby contributing to a deeper understanding of cancer biology and potential therapeutic targets.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
pan CEA Antibody (B-1) References:
- Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. | Saha, A., et al. 2004. Cancer Res. 64: 4995-5003. PMID: 15256474
- Preparation of carcinoembryonic antigen (CEA) containing significantly increased amounts of galactose and galactosamine. | Joung, JI., et al. 1975. Prep Biochem. 5: 359-74. PMID: 171642
- Enhancement of carcinoembryonic antigen (CEA) expression in colorectal tumors by neuraminidase. | Dejica, DI., et al. 1991. Roum Arch Microbiol Immunol. 50: 199-207. PMID: 1726506
- Immunological characteristics of monoclonal antibodies against human carcinoembryonic antigen (CEA). | Tsai, LC., et al. 1985. Proc Natl Sci Counc Repub China B. 9: 287-97. PMID: 2419936
- Interconversion between two electrophoretic forms of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA). | Krop-Watorek, A., et al. 1989. Arch Immunol Ther Exp (Warsz). 37: 703-14. PMID: 2487380
- Diagnostic usefulness of plasma carcinoembryonic antigen (CEA) levels in Crohn's disease. | Meryn, S. and Lochs, H. 1983. Dig Dis Sci. 28: 478-9. PMID: 6839911
- Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease. | Staab, HJ. and Anderer, FA. 1983. Cancer Detect Prev. 6: 33-9. PMID: 6883391
- Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancer. | Sugarbaker, PH., et al. 1978. Cancer. 42: 1434-6. PMID: 709512
- The carcinoembryonic antigen of the digestive system (CEA) and the antigens cross-reacting with it. | Burtin, P. 1978. Ann Immunol (Paris). 129: 185-98. PMID: 79326
- Heterogeneity of carcinoembryonic antigen. I. Concanavalin A-reactive and -nonreactive CEA. | Kosaki, G. and Yamamoto, T. 1975. Ann N Y Acad Sci. 259: 366-76. PMID: 812411
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
pan CEA Antibody (B-1) | sc-398456 | 200 µg/ml | $322.00 | |||
pan CEA Antibody (B-1): m-IgGκ BP-HRP Bundle | sc-536063 | 200 µg Ab; 40 µg BP | $361.00 | |||
pan CEA Antibody (B-1): m-IgG2b BP-HRP Bundle | sc-549509 | 200 µg Ab; 10 µg BP | $361.00 | |||
pan CEA (B-1) Neutralizing Peptide | sc-398456 P | 100 µg/0.5 ml | $69.00 |